CRED Managing Variations Effectively

B. Quality Changes

I. Active Substance II. Finished Product III. CEP/TSE/monographs IV. Medical Devices V. Changes to a marketing authorisation resulting from other regulatory procedures ( changes affecting information provided in Module 3 of the dossier)

50

Introduction to Classification of CMC (Quality) / Clinical / PhV Variations